Who owns the OMNIVIUM PHARMACEUTICALS trademark?

The OMNIVIUM PHARMACEUTICALS trademark is owned by Omnivium Pharmaceuticals LLC.

What class is the OMNIVIUM PHARMACEUTICALS trademark registered in?

The OMNIVIUM PHARMACEUTICALS trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for OMNIVIUM PHARMACEUTICALS?

The USPTO serial number for OMNIVIUM PHARMACEUTICALS is 90839896.

What is the registration number for OMNIVIUM PHARMACEUTICALS?

OMNIVIUM PHARMACEUTICALS is registered under USPTO registration number 7495809.

OMNIVIUM PHARMACEUTICALS - Owned by Omnivium Pharmaceuticals LLC - (Class 005)

What to file next

Section 8 declaration of continued use

When: Due between the fifth and sixth anniversary of registration.
Extensions and grace: A six-month grace period follows, with an added per-class fee.
If it is missed: A missed Section 8 cancels the registration, and there is no revival route for it.

How the Section 8 deadline works

General information about USPTO practice, not legal advice. The register is the authority, and a filing that has not yet posted can change what is owed.

Full Goods & Services

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Oct 15, 2023

First use in commerce: Oct 15, 2023

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

This description is as filed with the USPTO and defines the scope of trademark protection.

Filing Basis & Declarations

Use Application CurrentlyTrademark

Status History

34 events

REGISTERED-PRINCIPAL REGISTER

Sep 03, 2024

Code R.PR

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Sep 03, 2024

Code NRCC

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jul 31, 2024

Code CNPR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jul 31, 2024

Code SUNA

ASSIGNED TO LIE

Jul 30, 2024

Code ALIE

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jul 30, 2024

Code CRFA

TEAS/EMAIL CORRESPONDENCE ENTERED

Jul 30, 2024

Code TEME

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Feb 09, 2024

Code TROA

NON-FINAL ACTION E-MAILED

Dec 28, 2023

Code GNRT

SU - NON-FINAL ACTION - WRITTEN

Dec 28, 2023

Code CNRT

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Dec 28, 2023

Code GNRN

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Dec 05, 2023

Code AITU

STATEMENT OF USE PROCESSING COMPLETE

Dec 05, 2023

Code SUPC

TEAS STATEMENT OF USE RECEIVED

Nov 22, 2023

Code EISU

USE AMENDMENT FILED

Nov 22, 2023

Code IUAF

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

May 24, 2023

Code EXRA

SOU EXTENSION 1 FILED

May 22, 2023

Code EXT1

SOU TEAS EXTENSION RECEIVED

May 22, 2023

Code EEXT

SOU EXTENSION 1 GRANTED

May 22, 2023

Code EX1G

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Nov 22, 2022

Code NOAM

PUBLISHED FOR OPPOSITION

Sep 27, 2022

Code PUBO

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Sep 27, 2022

Code NPUB

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Sep 07, 2022

Code NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Aug 25, 2022

Code CNSA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Aug 24, 2022

Code TROA

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 24, 2022

Code CRFA

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 24, 2022

Code TEME

NON-FINAL ACTION WRITTEN

Apr 21, 2022

Code CNRT

NON-FINAL ACTION E-MAILED

Apr 21, 2022

Code GNRT

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Apr 21, 2022

Code GNRN

ASSIGNED TO EXAMINER

Apr 14, 2022

Code DOCK

NOTICE OF DESIGN SEARCH CODE E-MAILED

Sep 23, 2021

Code MDSC

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 22, 2021

Code NWOS

NEW APPLICATION ENTERED

Jul 24, 2021

Code NWAP

Other Marks by Omnivium Pharmaceuticals LLC

Additional USPTO filings from the same owner.

OMN

OMNIVIUM PHARMACEUTICALS

90839922

Omnivium Pharmaceuticals LLC

REGISTERED

NUM

NUMBRINO

87004857

OMNIVIUM PHARMACEUTICALS LLC

REGISTERED

OMN

OMNIVIUM

90839914

Omnivium Pharmaceuticals LLC

ABANDONED

OMN

OMNIVIUM PHARMA

90839919

Omnivium Pharmaceuticals LLC

ABANDONED

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Recently filed and registered marks in the same international class.

OMN

OMNIVIUM PHARMACEUTICALS

90839922

Omnivium Pharmaceuticals LLC

REGISTERED

HOP

HOPE PHARMACEUTICALS

78833609

HOPE MEDICAL ENTERPRISES, INC.

REGISTERED

BRO

BROOKFIELD PHARMACEUTICALS

99119920

Brookfield Pharmaceuticals, LLC

REGISTERED

MIL

MILESTONE PHARMACEUTICALS

88499919

Milestone Pharmaceuticals USA, Inc.

REGISTERED

Other Marks by Michael C. Cannata

Additional USPTO filings handled by the same attorney of record.

INT

IN THE SHED

88815243

REGISTERED

MUS

MUSCULOSKELETAL RESOURCES

88692234

REGISTERED

MON

MONEY LIKE A WOMAN

98978546

REGISTERED

LET

LET'S MONEY TOGETHER

98978567

REGISTERED

OMNIVIUM PHARMACEUTICALS

What to file next

Full Goods & Services

Filing Basis & Declarations

Other Marks by Omnivium Pharmaceuticals LLC

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Michael C. Cannata

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Industries

USPTO Deadlines

Compare

Resources

Company

Exceptions